Literature DB >> 9871528

Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2' groups.

J D Rodgers1, B L Johnson, H Wang, S Erickson-Viitanen, R M Klabe, L Bacheler, B C Cordova, C H Chang.   

Abstract

Cyclic ureas containing 3-aminoindazole P2/P2' groups are extremely potent inhibitors of HIV protease. The parent 3-aminoindazole 6 showed a Ki < 0.01 nM but poor translation of enzyme activity to antiviral activity was observed. A series of 3-alkylaminoindazoles revealed that translation improved with increasing lipophilicity. An X-ray crystal structure of 6 bound to HIV protease was obtained.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871528     DOI: 10.1016/s0960-894x(98)00118-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Multiple receptor conformation docking and dock pose clustering as tool for CoMFA and CoMSIA analysis - a case study on HIV-1 protease inhibitors.

Authors:  Sree Kanth Sivan; Vijjulatha Manga
Journal:  J Mol Model       Date:  2011-05-06       Impact factor: 1.810

2.  Selective L-nitroargininylaminopyrrolidine and L-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors.

Authors:  Jiwon Seo; Pavel Martásek; Linda J Roman; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2007-01-04       Impact factor: 3.641

3.  Identification of novel HIV 1--protease inhibitors: application of ligand and structure based pharmacophore mapping and virtual screening.

Authors:  Divya Yadav; Sarvesh Paliwal; Rakesh Yadav; Mahima Pal; Anubhuti Pandey
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

4.  α-Glucosidase inhibitory activity and cytotoxic effects of some cyclic urea and carbamate derivatives.

Authors:  Jelena B Popović-Djordjević; Ivana I Jevtić; Nadja Dj Grozdanić; Sandra B Šegan; Mario V Zlatović; Milovan D Ivanović; Tatjana P Stanojković
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.